Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001193125-26-089102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-02 | RARE | Huang Dennis Karl | See Remarks | F - Tax | $23.39 | -999 | 124.7K | -0.8% | -$23.4K | |
| 2026-03-03 | 2026-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +11.1K | 125.7K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | F | D | 999 | $23.39 | 124,729 | D | — | — | (F2) Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. (F3) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2026-03-01 | A | A | 11,137 | $0.00 | 125,728 | D | — | — | (F1) Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metric. |